Chest ACCP Career Connection
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text Free
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (33)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bouros, D.
Right arrow Articles by Zeibecoglou, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bouros, D.
Right arrow Articles by Zeibecoglou, K.
(Chest. 2002;121:1278-1289.)
© 2002 American College of Chest Physicians

Association of Malignancy With Diseases Causing Interstitial Pulmonary Changes*

Demosthenes Bouros, MD, FCCP; Kostas Hatzakis, MD; Haris Labrakis, MD and Kyriaki Zeibecoglou, MD, PhD

* From the Department of Pneumonology, Medical School University of Crete, Crete, Greece.

Correspondence to: Demosthenes Bouros, MD, FCCP, Associate Professor of Pneumonology, Department of Pneumonology, Medical School, University of Crete and University Hospital, 711 10 Heraklion, Crete, Greece; e-mail: bouros{at}med.uoc.gr

A number of studies have shown a high incidence of lung cancer in patients with idiopathic pulmonary fibrosis (9.8 to 38%) compared to control subjects (2 to 6.4%). A similar trend occurs in other entities that affect the interstitial lung compartment, such as systemic sclerosis and sarcoidosis, as well as occupational diseases. The pathogenesis of lung cancer in patients with diffuse pulmonary fibrosis is still unclear. Recent progress in molecular and cellular biology has shed some light on the possible interactions of several types of inflammatory cells, following the deleterious effects of toxic factors leading to alveolitis, and destruction and disorganization of lung parenchyma, which results in fibrosis. Further research in the field would enhance our understanding of the pathogenic mechanisms of cancer development in these patients, and to explain the reason for the different incidence of lung cancer in patients with various interstitial lung diseases.

Key Words: asbestosis • cancer • lung cancer • malignancy • pulmonary fibrosis • sarcoidosis • scar cancer




This article has been cited by other articles:


Home page
 Am. J. Respir. Crit. Care Med.Home page
D. D. Sin, S. F. P. Man, A. McWilliams, and S. Lam
Progression of Airway Dysplasia and C-Reactive Protein in Smokers at High Risk of Lung Cancer
Am. J. Respir. Crit. Care Med., March 1, 2006; 173(5): 535 - 539.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
D. Bouros and K. M. Antoniou
Current and future therapeutic approaches in idiopathic pulmonary fibrosis
Eur. Respir. J., October 1, 2005; 26(4): 693 - 703.
[Abstract] [Full Text] [PDF]

Home page
 RadiologyHome page
D. A. Lynch, W. D. Travis, N. L. Muller, J. R. Galvin, D. M. Hansell, P. A. Grenier, and T. E. King Jr
Idiopathic Interstitial Pneumonias: CT Features
Radiology, July 1, 2005; 236(1): 10 - 21.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
S Wasswa-Kintu, W Q Gan, S F P Man, P D Pare, and D D Sin
Relationship between reduced forced expiratory volume in one second and the risk of lung cancer: a systematic review and meta-analysis
Thorax, July 1, 2005; 60(7): 570 - 575.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
S. Lantuejoul, T.V. Colby, G.R. Ferretti, P.Y. Brichon, C. Brambilla, and E. Brambilla
Adenocarcinoma of the lung mimicking inflammatory lung disease with honeycombing
Eur. Respir. J., September 1, 2004; 24(3): 502 - 505.
[Abstract] [Full Text] [PDF]

Home page
 Ann Rheum DisHome page
N Feltelius, A Ekbom, and P Blomqvist
Cancer incidence among patients with ankylosing spondylitis in Sweden 1965-95: a population based cohort study
Ann Rheum Dis, December 1, 2003; 62(12): 1185 - 1188.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
T. Fujimoto, T. Okazaki, T. Matsukura, T. Hanawa, N. Yamashita, K. Nishimura, M. Kuwabara, and Y. Matsubara
Operation for lung cancer in patients with idiopathic pulmonary fibrosis: surgical contraindication?
Ann. Thorac. Surg., November 1, 2003; 76(5): 1674 - 1678.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
H. Suzuki, K. Aoshiba, N. Yokohori, and A. Nagai
Epidermal Growth Factor Receptor Tyrosine Kinase Inhibition Augments a Murine Model of Pulmonary Fibrosis
Cancer Res., August 15, 2003; 63(16): 5054 - 5059.
[Abstract] [Full Text] [PDF]

Home page
 Ann Rheum DisHome page
J E Pearson and A J Silman
Risk of cancer in patients with scleroderma
Ann Rheum Dis, August 1, 2003; 62(8): 697 - 699.
[Full Text] [PDF]

Home page
 Hum Mol GenetHome page
C. K. Haston, M. Wang, R. E. Dejournett, X. Zhou, D. Ni, X. Gu, T. M. King, M. M. Weil, R. A. Newman, C. I. Amos, et al.
Bleomycin hydrolase and a genetic locus within the MHC affect risk for pulmonary fibrosis in mice
Hum. Mol. Genet., August 1, 2002; 11(16): 1855 - 1863.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2002 by the American College of Chest Physicians.